Comparing the Efficacy and Safety of Nemolizumab Versus Anti-interleukin Monoclonal Antibody Therapies in Combination with Topical Treatments for Moderate-to-Severe Atopic Dermatitis Using Network Meta-analysis.
Saved in:
| Title: | Comparing the Efficacy and Safety of Nemolizumab Versus Anti-interleukin Monoclonal Antibody Therapies in Combination with Topical Treatments for Moderate-to-Severe Atopic Dermatitis Using Network Meta-analysis. |
|---|---|
| Authors: | Pink, Andrew E.1 (AUTHOR), Houghton, John2 (AUTHOR), White, Holly2 (AUTHOR), Schiavo, Sofia2 (AUTHOR), Piketty, Christophe3 (AUTHOR), Ulianov, Liliana3 (AUTHOR), Rout, Rajesh3 (AUTHOR), Jack, Katrin3 (AUTHOR), Subramanian, Ramkumar3 (AUTHOR), Puelles, Jorge3 (AUTHOR) Jorge.Puelles@galderma.com |
| Source: | Dermatology & Therapy. Feb2026, Vol. 16 Issue 2, p1347-1365. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-025-01647-0 |
